Comparison Between Patients Hospitalized with Influenza and COVID-19 at a Tertiary Care Center
Overview
Authors
Affiliations
Background: Widespread reports suggest the characteristics and disease course of coronavirus disease 2019 (COVID-19) and influenza differ, yet detailed comparisons of their clinical manifestations are lacking.
Objective: Comparison of the epidemiology and clinical characteristics of COVID-19 patients during the pandemic with those of influenza patients in previous influenza seasons at the same hospital DESIGN: Admission rates, clinical measurements, and clinical outcomes from confirmed COVID-19 cases between March 1 and April 30, 2020, were compared with those from confirmed influenza cases in the previous five influenza seasons (8 months each) beginning September 1, 2014.
Setting: Large tertiary care teaching hospital in Boston, MA PARTICIPANTS: Laboratory-confirmed COVID-19 and influenza inpatients MEASUREMENTS: Patient demographics and medical history, mortality, incidence and duration of mechanical ventilation, incidences of vasopressor support and renal replacement therapy, and hospital and intensive care admissions.
Results: Data was abstracted from medical records of 1052 influenza patients and 582 COVID-19 patients. An average of 210 hospital admissions for influenza occurred per 8-month season compared to 582 COVID-19 admissions over 2 months. The median weekly number of COVID-19 patients requiring mechanical ventilation was 17 (IQR: 4, 34) compared to a weekly median of 1 (IQR: 0, 2) influenza patient (p=0.001). COVID-19 patients were significantly more likely to require mechanical ventilation (31% vs 8%) and had significantly higher mortality (20% vs. 3%; p<0.001 for all). Relatively more COVID-19 patients on mechanical ventilation lacked pre-existing conditions compared with mechanically ventilated influenza patients (25% vs 4%, p<0.001). Pneumonia/ARDS secondary to the virus was the predominant cause of mechanical ventilation in COVID-19 patients (94%) as opposed to influenza (56%).
Limitation: This is a single-center study which could limit generalization.
Conclusion: COVID-19 resulted in more weekly hospitalizations, higher morbidity, and higher mortality than influenza at the same hospital.
Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H Pneumonia (Nathan). 2025; 17(1):3.
PMID: 39905566 PMC: 11796215. DOI: 10.1186/s41479-025-00158-y.
Han Y, Guo J, Li X, Zhong Z NPJ Prim Care Respir Med. 2025; 35(1):8.
PMID: 39875405 PMC: 11775258. DOI: 10.1038/s41533-025-00414-0.
Comparing adults with severe SARS-CoV-2 or influenza infection: South Africa, 2016-2021.
Els F, Kleynhans J, Wolter N, du Plessis M, Moosa F, Tempia S S Afr J Infect Dis. 2024; 39(1):574.
PMID: 39114258 PMC: 11304391. DOI: 10.4102/sajid.v39i1.574.
Kopel H, Bogdanov A, Winer-Jones J, Adams C, Winer I, Bonafede M Diseases. 2024; 12(1).
PMID: 38248367 PMC: 10814040. DOI: 10.3390/diseases12010016.
Yeung-Luk B, Narayanan G, Ghosh B, Wally A, Lee E, Mokaya M mBio. 2023; 14(4):e0082023.
PMID: 37504520 PMC: 10470579. DOI: 10.1128/mbio.00820-23.